Vitreo Retinal Surgery Devices - Medical Devices Pipeline Product Landscape, 2021

Vitreo Retinal Surgery Devices - Medical Devices Pipeline Product Landscape, 2021

Summary

GlobalData's Medical Devices sector report, “Vitreo Retinal Surgery Devices - Medical Devices Pipeline Product Landscape, 2021 provides comprehensive information about the Vitreo Retinal Surgery Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Vitreo retinal surgical devices are used for surgical procedures that treat eye problems involving the retina, macula, and vitreous fluid. These devices include vitreo retinal surgical packs, related oils and fluids used for the vitreo retinal surgery.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Vitreo Retinal Surgery Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Vitreo Retinal Surgery Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Vitreo Retinal Surgery Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


  • About GlobalData
  • Introduction
    • Vitreo Retinal Surgery Devices Overview
  • Products under Development
    • Vitreo Retinal Surgery Devices - Pipeline Products by Stage of Development
      • Table Figure 1: Vitreo Retinal Surgery Devices - Pipeline Products by Stage of Development
      • Table Vitreo Retinal Surgery Devices - Pipeline Products by Stage of Development
    • Vitreo Retinal Surgery Devices - Pipeline Products by Territory
      • Table Figure 2: Vitreo Retinal Surgery Devices - Pipeline Products by Territory
      • Table Vitreo Retinal Surgery Devices - Pipeline Products by Territory
    • Vitreo Retinal Surgery Devices - Pipeline Products by Regulatory Path
      • Table Figure 3: Vitreo Retinal Surgery Devices - Pipeline Products by Regulatory Path
      • Table Vitreo Retinal Surgery Devices - Pipeline Products by Regulatory Path
    • Vitreo Retinal Surgery Devices - Pipeline Products by Estimated Approval Date
      • Table Figure 4: Vitreo Retinal Surgery Devices - Pipeline Products by Estimated Approval Date
      • Table Vitreo Retinal Surgery Devices - Pipeline Products by Estimated Approval Date
    • Vitreo Retinal Surgery Devices - Ongoing Clinical Trials
      • Table Figure 5: Vitreo Retinal Surgery Devices - Ongoing Clinical Trials
      • Table Vitreo Retinal Surgery Devices - Ongoing Clinical Trials
  • Vitreo Retinal Surgery Devices - Pipeline Products under Development by Companies
    • Vitreo Retinal Surgery Devices Companies - Pipeline Products by Stage of Development
      • Table Vitreo Retinal Surgery Devices Companies - Pipeline Products by Stage of Development
    • Vitreo Retinal Surgery Devices - Companies Pipeline Products by Stage of Development
      • Table Vitreo Retinal Surgery Devices - Companies Pipeline Products by Stage of Development
    • ABVC BioPharma Inc Company Overview
      • ABVC BioPharma Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ABVC BioPharma Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vitargus - Product Status
        • Table Vitargus - Product Description
        • Table ABVC BioPharma Inc - Ongoing Clinical Trials Overview
        • Table Vitargus - A Prospective Multi-site Randomized Controlled Clinical Investigation of the Safety and Effectiveness of the ABV1701 Ocular Endotamponade (OE)
    • AcuSurgical Company Overview
      • AcuSurgical Pipeline Products & Ongoing Clinical Trials Overview
        • Table AcuSurgical Pipeline Products & Ongoing Clinical Trials Overview
        • Table Robotic Surgical Assistant - Product Status
        • Table Robotic Surgical Assistant - Product Description
    • Alcon Inc Company Overview
      • Alcon Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Alcon Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table FINESSE REFLEX Handle - Product Status
        • Table FINESSE REFLEX Handle - Product Description
        • Table New CONSTELLATION Vitreoretinal System - Product Status
        • Table New CONSTELLATION Vitreoretinal System - Product Description
        • Table Next Generation Vitreo-retinal System - Product Status
        • Table Next Generation Vitreo-retinal System - Product Description
    • Bausch & Lomb Inc Company Overview
      • Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table BLS - 005: Retina - Product Status
        • Table BLS - 005: Retina - Product Description
        • Table BLS - 009: Retina - Product Status
        • Table BLS - 009: Retina - Product Description
        • Table BLS - 012: Retina - Product Status
        • Table BLS - 012: Retina - Product Description
        • Table BLS - 013: Retina - Product Status
        • Table BLS - 013: Retina - Product Description
        • Table BLS - 018: Retina - Product Status
        • Table BLS - 018: Retina - Product Description
        • Table BLS - 019: Retina - Product Status
        • Table BLS - 019: Retina - Product Description
        • Table BLS - 020: Retina - Product Status
        • Table BLS - 020: Retina - Product Description
        • Table BLS - 021: Retina - Product Status
        • Table BLS - 021: Retina - Product Description
        • Table BLS - 022: Retina - Product Status
        • Table BLS - 022: Retina - Product Description
        • Table BLS - 023: Retina - Product Status
        • Table BLS - 023: Retina - Product Description
        • Table BLS - 024: Retina - Product Status
        • Table BLS - 024: Retina - Product Description
        • Table BLS - 025: Retina - Product Status
        • Table BLS - 025: Retina - Product Description
        • Table BLS - 026: Retina - Product Status
        • Table BLS - 026: Retina - Product Description
        • Table BLS - 027: Retina - Product Status
        • Table BLS - 027: Retina - Product Description
        • Table BLS - 028: Retina - Product Status
        • Table BLS - 028: Retina - Product Description
        • Table BLS - 029: Retina - Product Status
        • Table BLS - 029: Retina - Product Description
        • Table BLS - 030: Retina - Product Status
        • Table BLS - 030: Retina - Product Description
        • Table BLS - 031: Retina - Product Status
        • Table BLS - 031: Retina - Product Description
    • Beaver-Visitec International Inc Company Overview
      • Beaver-Visitec International Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Beaver-Visitec International Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Velvet - Product Status
        • Table Velvet - Product Description
    • Boston College Company Overview
      • Boston College Pipeline Products & Ongoing Clinical Trials Overview
        • Table Boston College Pipeline Products & Ongoing Clinical Trials Overview
        • Table Visual Prosthetic Device - Product Status
        • Table Visual Prosthetic Device - Product Description
    • Cambridge Polymer Group Inc Company Overview
      • Cambridge Polymer Group Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cambridge Polymer Group Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Retinal Tamponade - Product Status
        • Table Retinal Tamponade - Product Description
    • Carnegie Mellon University Company Overview
      • Carnegie Mellon University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Carnegie Mellon University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Micron - Product Status
        • Table Micron - Product Description
    • Johns Hopkins University Company Overview
      • Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Microsurgical Tool - Product Status
        • Table Microsurgical Tool - Product Description
    • King's College London Company Overview
      • King's College London Pipeline Products & Ongoing Clinical Trials Overview
        • Table King's College London Pipeline Products & Ongoing Clinical Trials Overview
        • Table DOF - Haptic Device - Product Status
        • Table DOF - Haptic Device - Product Description
    • Medisse BV (Inactive) Company Overview
      • Medisse BV (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Medisse BV (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table PTMC Scleral Buckle - Product Status
        • Table PTMC Scleral Buckle - Product Description
    • RetinaSense Company Overview
      • RetinaSense Pipeline Products & Ongoing Clinical Trials Overview
        • Table RetinaSense Pipeline Products & Ongoing Clinical Trials Overview
        • Table RetinaSense Device - Product Status
        • Table RetinaSense Device - Product Description
    • Synergetics USA, Inc. (Inactive) Company Overview
      • Synergetics USA, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Synergetics USA, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Intraoperative Device - Product Status
        • Table Intraoperative Device - Product Description
    • The Chinese University of Hong Kong Company Overview
      • The Chinese University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview
        • Table The Chinese University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview
        • Table Scleral Buckles - Product Status
        • Table Scleral Buckles - Product Description
    • University of Kansas Company Overview
      • University of Kansas Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Kansas Pipeline Products & Ongoing Clinical Trials Overview
        • Table Subretinal Fluid Drainage Cannula - Product Status
        • Table Subretinal Fluid Drainage Cannula - Product Description
    • University of Minnesota Company Overview
      • University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
        • Table Scleral Depressor System - Product Status
        • Table Scleral Depressor System - Product Description
  • Vitreo Retinal Surgery Devices- Recent Developments
    • Nov 02, 2021: Bausch Health Companies Announces Third-Quarter 2021 Results
    • Sep 29, 2021: Bausch Health Releases Annual Environmental, Social and Governance Report
    • Aug 03, 2021: Bausch Health Announces Second-Quarter 2021 Results
    • Jul 27, 2021: Pixium Vision announces its financial results for H1 2021 and provides a business update
    • Jul 06, 2021: Bausch Health Companies Will Release Second-Quarter 2021 Financial Results On August 3
    • May 05, 2021: Nanoscope presents novel gene delivery and electrophysiology platforms at ARVO
    • May 04, 2021: Bausch Health Companies Announces First-Quarter 2021 Results
    • Apr 28, 2021: Bausch Health Announces 2021 Annual Meeting of Shareholder Results
    • Apr 09, 2021: Bausch Health will Release First-Quarter 2021 Financial Results on May 4, 2021
    • Mar 09, 2021: Continuation of the business combination project between Pixium Vision et Second Sight Medical Products
    • Mar 09, 2021: Bausch Health Publishes Pipeline Update For The Barclays Global Healthcare Conference
    • Mar 08, 2021: U of M Vice President for Research Chris Cramer announces departure from the University for national research opportunity
    • Feb 17, 2021: U of M's Technological Leadership Institute names Professor Allison Hubel new director
    • Feb 09, 2021: Global medical technology manufacturer selects IFS for business efficiency and legal compliance
    • Jan 27, 2021: Bausch Health Will Release Fourth-Quarter And Full-Year 2020 Financial Results On February 24
    • Jan 06, 2021: Pixium Vision and Second Sight Medical Products announce business combination, creating a global leader in the sight restoration market
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings